☰

Elizabeth J. Rahn, Ph.D., M.S. - Publications

Affiliations: 
Neurobiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Pain, Cannabinoids, Neuropsychopharmacology, Epigenetics
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

11/34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Danila MI, Allison JJ, Goins KV, Chiriboga G, Fischer M, Puliafico M, Mudano AS, Rahn EJ, Merchant J, Lawrence CE, Dunkel L, Israel T, Barton B, Jenoure F, Alexander T, et al. Development of a multi-component intervention to promote participation of Black and Latinx individuals in biomedical research. Journal of Clinical and Translational Science. 5: e134. PMID 34367678 DOI: 10.1017/cts.2021.797  0.396
2020 Lawrence CE, Dunkel L, McEver M, Israel T, Taylor R, Chiriboga G, Goins KV, Rahn EJ, Mudano AS, Roberson ED, Chambless C, Wadley VG, Danila MI, Fischer MA, Joosten Y, et al. A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent. Journal of Clinical and Translational Science. 4: 345-353. PMID 33244416 DOI: 10.1017/cts.2020.30  0.405
2016 Kennedy AJ, Rahn EJ, Paulukaitis BS, Savell KE, Kordasiewicz HB, Wang J, Lewis JW, Posey J, Strange SK, Guzman-Karlsson MC, Phillips SE, Decker K, Motley ST, Swayze EE, Ecker DJ, et al. Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function. Cell Reports. PMID 27568567 DOI: 10.1016/J.Celrep.2016.08.004  0.581
2014 Rahn EJ, Deng L, Thakur GA, Vemuri K, Zvonok AM, Lai YY, Makriyannis A, Hohmann AG. Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery. Molecular Pain. 10: 27. PMID 24742127 DOI: 10.1186/1744-8069-10-27  0.6
2011 Rahn EJ, Thakur GA, Wood JA, Zvonok AM, Makriyannis A, Hohmann AG. Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects. Pharmacology, Biochemistry, and Behavior. 98: 493-502. PMID 21382397 DOI: 10.1016/J.Pbb.2011.02.024  0.581
2010 Rahn EJ, Zvonok AM, Makriyannis A, Hohmann AG. Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation. The Aaps Journal. 12: 147-57. PMID 20127295 DOI: 10.1208/S12248-009-9170-8  0.578
2009 Rahn EJ, Hohmann AG. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 713-37. PMID 19789075 DOI: 10.1016/J.Nurt.2009.08.002  0.565
2008 Rahn EJ, Zvonok AM, Thakur GA, Khanolkar AD, Makriyannis A, Hohmann AG. Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats. The Journal of Pharmacology and Experimental Therapeutics. 327: 584-91. PMID 18664590 DOI: 10.1124/Jpet.108.141994  0.635
2007 Rahn EJ, Makriyannis A, Hohmann AG. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. British Journal of Pharmacology. 152: 765-77. PMID 17572696 DOI: 10.1038/Sj.Bjp.0707333  0.628
2007 Rahn E, Hohmann A. 289 CANNABINOIDS SUPPRESS CHEMOTHERAPY-EVOKED PAINFUL PERIPHERAL NEUROPATHY THROUGH SPINAL SITES OF ACTION European Journal of Pain. 11: S128-S128. DOI: 10.1016/J.Ejpain.2007.03.304  0.566
2007 Hohmann A, Rahn E, Maxwell K, Zvonok A, Makriyannis A. 276 SELECTIVE ACTIVATION OF CANNABINOID CB2 RECEPTORS SUPPRESSES CHEMOTHERAPEUTIC NEUROPATHY EVOKED BY PACLITAXEL AND VINCRISTINE ADMINISTRATION European Journal of Pain. 11: S122-S122. DOI: 10.1016/J.Ejpain.2007.03.291  0.588
Low-probability matches (unlikely to be authored by this person)
2013 Rahn EJ, Guzman-Karlsson MC, David Sweatt J. Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memory. Neurobiology of Learning and Memory. 105: 133-50. PMID 23796633 DOI: 10.1016/j.nlm.2013.06.008  0.241
2014 Rahn EJ, Iannitti T, Donahue RR, Taylor BK. Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus. Biology of Sex Differences. 5: 4. PMID 24581045 DOI: 10.1186/2042-6410-5-4  0.194
2018 Lessans S, Lassiter CB, Carozzi V, Heindel P, Semperboni S, Oggioni N, Chiorazzi A, Thompson C, Wagner M, Holden J, Rahn E, David Sweatt J, Cavaletti G, Renn CL, Dorsey SG. Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral Neuropathy. Nursing Research. PMID 30586060 DOI: 10.1097/Nnr.0000000000000338  0.133
2020 Goddard KAB, Angelo FAN, Ackerman SL, Berg JS, Biesecker BB, Danila MI, East KM, Hindorff LA, Horowitz CR, Hunter JE, Joseph G, Knight SJ, McGuire A, Muessig KR, Ou J, ... ... Rahn EJ, et al. Lessons learned about harmonizing survey measures for the CSER consortium. Journal of Clinical and Translational Science. 4: 537-546. PMID 33948230 DOI: 10.1017/cts.2020.41  0.076
2018 Danila MI, Outman RC, Rahn EJ, Mudano AS, Redden DT, Li P, Allison JJ, Anderson FA, Wyman A, Greenspan SL, LaCroix AZ, Nieves JW, Silverman SL, Siris ES, Watts NB, et al. Evaluation of a Multi-modal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis: A Randomized Clinical Trial. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 29377378 DOI: 10.1002/Jbmr.3395  0.069
2019 Adami G, Rahn EJ, Saag KG. Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice. Therapeutic Advances in Musculoskeletal Disease. 11: 1759720X19876468. PMID 31565078 DOI: 10.1177/1759720X19876468  0.069
2016 Cohen JL, Ata AE, Jackson NL, Rahn EJ, Ramaker RC, Cooper S, Kerman IA, Clinton SM. Differential stress induced c-Fos expression and identification of region-specific miRNA-mRNA networks in the dorsal raphe and amygdala of high-responder/low-responder rats. Behavioural Brain Research. PMID 27865919 DOI: 10.1016/J.Bbr.2016.11.015  0.069
2016 Saddekni MB, Saag KG, Dudenbostel T, Oparil S, Calhoun DA, Sattui SE, Feig DI, Muntner P, Redden DT, Foster PJ, Rahn EJ, Biggers SR, Li P, Gaffo AL. The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale. Contemporary Clinical Trials. PMID 27587282 DOI: 10.1016/J.Cct.2016.08.016  0.066
2016 Danila MI, Outman RC, Rahn EJ, Mudano AS, Thomas TF, Redden DT, Allison JJ, Anderson FA, Anderson JP, Cram PM, Curtis JR, Fraenkel L, Greenspan SL, LaCroix AZ, Majumdar SR, et al. A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material. Contemporary Clinical Trials Communications. 4: 14-24. PMID 27453960 DOI: 10.1016/J.Conctc.2016.06.010  0.062
2020 Rosas G, Gaffo A, Rahn EJ, Saag KG. Cardiovascular safety risks associated with gout treatments. Expert Opinion On Drug Safety. PMID 32731769 DOI: 10.1080/14740338.2020.1804551  0.059
2021 Gaffo AL, Calhoun DA, Rahn EJ, Oparil S, Li P, Dudenbostel T, Feig DI, Redden DT, Muntner P, Foster PJ, Biggers-Clark SR, Mudano A, Sattui SE, Saddekni MB, Bridges SL, et al. Effect of serum urate lowering with allopurinol on blood pressure in young adults: A randomized, controlled, crossover trial. Arthritis & Rheumatology (Hoboken, N.J.). PMID 33779064 DOI: 10.1002/art.41749  0.057
2019 Chaudhary NS, Bridges SL, Saag KG, Rahn EJ, Curtis JR, Gaffo A, Limdi NA, Levitan EB, Singh JA, Colantonio LD, Howard G, Cushman M, Flaherty ML, Judd S, Irvin MR, et al. Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11913. PMID 31786980 DOI: 10.1161/Hypertensionaha.119.13580  0.055
2015 Escobar M, Suits WT, Rahn EJ, Arcediano F. Do long delay conditioned stimuli develop inhibitory properties? Frontiers in Psychology. 6: 1606. PMID 26557103 DOI: 10.3389/Fpsyg.2015.01606  0.055
2020 Taylor W, Dalbeth N, Singh JA, Rahn EJ, Mudano AS, Chen YH, Lin CT, Tan P, Louthreno W, Vazquez-Mellado J, Hernández-Llinas H, Neogi T, Vargas-Santos AB, Castelar-Pinheiro G, Chaves-Amorim RB, et al. Flare rate thresholds for patient assessment of gout disease activity states. The Journal of Rheumatology. PMID 32358154 DOI: 10.3899/jrheum.191242  0.045
2022 East KM, Cochran ME, Kelley WV, Greve V, Finnila CR, Coleman T, Jennings M, Alexander L, Rahn EJ, Danila MI, Barsh G, Korf B, Cooper G. Education and Training of Non-Genetics Providers on the Return of Genome Sequencing Results in a NICU Setting. Journal of Personalized Medicine. 12. PMID 35330405 DOI: 10.3390/jpm12030405  0.041
2021 Shaffer A, Rahn E, Saag K, Mudano A, Gaffo A. Variation in serum urate levels in the absence of gout and urate lowering therapy. Bmc Rheumatology. 5: 32. PMID 34493347 DOI: 10.1186/s41927-021-00202-6  0.035
2020 Mrug S, Orihuela C, Rahn E, Mudano A, Foster J, Saag K, Gaffo A. Depressive Symptoms and the Effectiveness of a Urate-Lowering Therapy in a Clinical Trial. Acr Open Rheumatology. PMID 33216463 DOI: 10.1002/acr2.11192  0.034
2020 Miller MJ, Jou T, Danila MI, Mudano AS, Rahn EJ, Outman RC, Saag KG. Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication use. Research in Social & Administrative Pharmacy : Rsap. PMID 33011082 DOI: 10.1016/j.sapharm.2020.09.010  0.028
2020 Liu W, Ye S, Barton BA, Fischer MA, Lawrence C, Rahn EJ, Danila MI, Saag KG, Harris PA, Lemon SC, Allison JJ, Zhang B. Simulation-based power and sample size calculation for designing interrupted time series analyses of count outcomes in evaluation of health policy interventions. Contemporary Clinical Trials Communications. 17: 100474. PMID 31886433 DOI: 10.1016/J.Conctc.2019.100474  0.027
2012 Rahn EJ. Norman H. Rahn III, MD Radiology. 265: 982-982. DOI: 10.1148/radiol.12124038  0.021
2019 Zhang B, Liu W, Lemon SC, Barton BA, Fischer MA, Lawrence C, Rahn EJ, Danila MI, Saag KG, Harris PA, Allison JJ. Design, analysis, power, and sample size calculation for three-phase interrupted time series analysis in evaluation of health policy interventions. Journal of Evaluation in Clinical Practice. PMID 31429175 DOI: 10.1111/Jep.13266  0.019
2017 Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS, Chen YH, Lin CT, Bourke S, Louthrenoo W, Vazquez-Mellado J, Hernández-Llinas H, Neogi T, Vargas-Santos AB, da Rocha Castelar-Pinheiro G, et al. Validation of a definition for flare in patients with established gout. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29161469 DOI: 10.1002/Art.40381  0.017
2020 Jagpal A, Rahn EJ, Mudano AS, Dalbeth N, Taylor W, Saag KG, Singh JA, Cavagna L, Uhlig T, Perez-Ruiz F, McCarthy G, Gerritsen M, Stamp L, Vazquez Mellado J, Lin C, et al. Which factors predict discordance between a patient and physician on a gout flare? Rheumatology (Oxford, England). PMID 32793971 DOI: 10.1093/Rheumatology/Keaa413  0.014
Hide low-probability matches.